Poly-ɛ-caprolactone nanocapsules loaded with copaiba essential oil reduce inflammation and pain in mice
- 17 June 2023
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 642, 123147
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJournal of Controlled Release, 2012
- Nanostructured systems containing an essential oil: protection against volatilizationQuímica Nova, 2011
- Nonresolving InflammationCell, 2010
- Biodistribution study and identification of inflammatory sites using nanocapsules labeled with 99mTc–HMPAONuclear Medicine Communications, 2009
- Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic MucosaMolecular Pharmaceutics, 2009
- Chemical composition and anti-inflammatory activity of copaiba oils from Copaifera cearensis Huber ex Ducke, Copaifera reticulata Ducke and Copaifera multijuga Hayne—A comparative studyJournal of Ethnopharmacology, 2007
- Antinociceptive activity of Amazonian Copaiba oilsJournal of Ethnopharmacology, 2007
- Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systemsNanomedicine: Nanotechnology, Biology and Medicine, 2006
- Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2006
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983